a nonsignificant trendp = 0.24
ITM dose (continuous) explained 13% of the between-study variance (R 2 = 13.3%), with a nonsignificant trend toward diminishing analgesic benefit at higher doses (β = −2.48 SMD per mg; 95% CI: −6.61 to +1.64; p = 0.24).